Publications by authors named "Arzu Onar-Thomas"

Claim this Profile
P
Phase 3 randomized trial of post-irradiation chemotherapy in patients with newly diagnosed ependymoma, a report from the Children's Oncology Group.
Amy A Smith, Arzu Onar-Thomas, Shelly Lensing, James Dalton, Jeffrey Bennett

Neuro Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ototoxicity and cognitive outcomes among very young children treated for brain tumors: Findings from a multisite, prospective, longitudinal trial.
Heather M Conklin, Nicole A Salman, Johnnie K Bass, Jie Huang, Arzu Onar-Thomas

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4.
Jason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, Shelly Lensing, Azra H Ligon

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: MOADE: a multimodal autoencoder for dissociating bulk multi-omics data.
Jiao Sun, Ayesha A Malik, Tong Lin, Ayla Bratton, Yue Pan, Arzu Onar-Thomas

Genome Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival.
Authors Kyle S Smith, Sandeep K Dhanda, Catherine A Billups, Edgar Sioson, Congyu Lu, Arzu Onar-Thomas

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXR2 activation is not exclusive of CNS neuroblastoma.
Alexa N Siskar, Emily Hanzlik, Maria F Cardenas, Mohammad K Eldomery, Soniya Pinto, Arzu Onar-Thomas

Neuro Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: Bayesian Reappraisal of ACNS0332 and ACNS0334 Strengthens Subgroup Treatment Effects in High-Risk Pediatric Group 3 Medulloblastoma.
Guolian Kang, Sarah E S Leary, Arzu Onar-Thomas, Yimei Li

Neuro Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOADE: a multimodal autoencoder for dissociating bulk multi-omics data.
Jiao Sun, Ayesha A Malik, Tong Lin, Ayla Bratton, Yue Pan, Arzu Onar-Thomas

Genome Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MODE: high-resolution digital dissociation with deep multimodal autoencoder.
Jiao Sun, Ayesha A Malik, Tong Lin, Ayla Bratton, Yue Pan, Arzu Onar-Thomas

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target.
Shiekh Tanveer Ahmad, Yiran Li, Jesus Garcia-Lopez, Brian L Gudenas, Jennifer Hadley, Arzu Onar-Thomas

Cancer Cell· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group study.
Matthias A Karajannis, Arzu Onar-Thomas, Tong Lin, Patricia A Baxter, Daniel R Boué

Neuro Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Academic readiness among young children treated for brain tumors: a multisite, prospective, longitudinal trial.
Melanie R Somekh, Jason M Ashford, Michelle A Swain, Lana L Harder, Bonnie L Carlson-Green, Arzu Onar-Thomas

J Natl Cancer Inst· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single-institution study with molecular correlation.
Steven S Carey, Jie Huang, Jason R Myers, Roya Mostafavi, Brent A Orr, Arzu Onar-Thomas

Pediatr Blood Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dimensional Mediation Analysis with Network Mediators: Applications to Pediatric Acute Lymphoblastic Leukemia.
Jade Xiaoqing Wang, Zhao-Hua Lu, Wilburn E Reddick, Heather M Conklin, John O Glass, Arzu Onar-Thomas

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging mediation analysis for longitudinal outcomes: a case study of childhood brain tumor survivorship.
Yimei Li, Jade Xiaoqing Wang, Grace Chen Zhou, Heather M Conklin, Arzu Onar-Thomas

Stat Interface· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.
Marc Zuckermann, Chen He, Jared Andrews, Aditi Bagchi, Roketa Sloan-Henry, Arzu Onar-Thomas

Mol Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials.
Ashley S Margol, Annette M Molinaro, Arzu Onar-Thomas, Adam Resnick, Derek Hanson

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group.
Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, Thomas S Jacques, Pratiti Bandopadhayay

Neuro Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Database Studies in Oncology: A Call for Standards.
Scott D Ramsey, Arzu Onar-Thomas, Stephanie B Wheeler

J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computing Power and Sample Size for the False Discovery Rate in Multiple Applications.
Yonghui Ni, Anna Eames Seffernick, Arzu Onar-Thomas, Stanley B Pounds

Genes (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study.
Rishi R Lulla, Allen Buxton, Mark D Krailo, Margot A Lazow, Daniel R Boue, Arzu Onar-Thomas

Neurooncol Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the Rotterdam postoperative cerebellar mutism syndrome prediction model in patients undergoing surgery for medulloblastoma in a single institution.
Savannah Bush, Paul Klimo, Arzu Onar-Thomas, Jie Huang, Frederick A Boop

J Neurosurg Pediatr· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of methotrexate and 7-hydroxymethotrexate and delayed excretion in infants and young children with brain tumors.
Olivia Campagne, Jie Huang, Tong Lin, Wilburn E Reddick, Nicholas S Selvo, Arzu Onar-Thomas

Eur J Pharm Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian Adaptive Randomization: Full of Promise With a Helping of Caution.
Arzu Onar-Thomas

J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
Sarah E S Leary, Arzu Onar-Thomas, Jason Fangusaro, Nicholas G Gottardo, Kenneth Cohen

Pediatr Blood Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis